Results 121 to 130 of about 9,465,904 (238)

Immunomodulatory therapy in paediatric inflammatory bowel disease

open access: yesZdravniški Vestnik, 2013
Immunomodulatory drugs are indispensable in the treatment of children with both Crohn’s disease and ulcerative colitis, especially in maintaining remission.
András Arató
doaj  

The effect of 6-mercaptopurine and its derivatives on mammalian RNA-dependent RNA synthesis

open access: yes, 1974
The effect of 6-mercaptopurine (6-MP) and its nucleoside and nucleotide derivatives on the rate of RNA synthesis with reticulocyte RNA-dependent RNA polymerase has been examined. Of the 6-MP derivatives tested only 6-mercaptopurine ribo-5′-monophosphate (
Downey, Kathleen M   +3 more
core   +1 more source

Cephalothin as a Carrier of 6-Mercaptopurine for Targeting Cancer Tissues

open access: yesIraqi Journal of Pharmaceutical Sciences, 2017
A lower extracellular pH is one of the few well-documented physiological differences between tumour and normal tissues. On the other hand, elevated glutathione (GSH) level has been detected in many tumours compared with healthy surrounding tissues.
Mohammad H. Mohammad   +1 more
doaj  

Impact of Chronotherapy on 6-Mercaptopurine Metabolites in Inflammatory Bowel Disease: A Pilot Crossover Trial. [PDF]

open access: yesClin Transl Gastroenterol, 2023
Swanson GR   +9 more
europepmc   +1 more source

Gold Nanoparticles Enhance the Anti-Leukemia Action of a 6-Mercaptopurine Chemotherapeutic Agent

open access: yes, 2016
6-Mercaptopurine and its riboside derivatives are some of the most widely utilized anti-leukemic and anti-inflammatory drugs. Their short biological half-life and severe side effects limit their use.
Paul Podsiadlo (1990147)   +5 more
core   +1 more source

Early Initiation of Adalimumab Significantly Diminishes Postoperative Crohn's Disease Endoscopic Recurrence and Is Superior to 6-Mercaptopurine Therapy: An Open-Label, Randomized Controlled Study. [PDF]

open access: yesJ Clin Med, 2023
Hirsch A   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy